We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+12.83%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$63.1B
AUM Growth
+$3.79B
Cap. Flow
-$1.12B
Cap. Flow %
-1.77%
Top 10 Hldgs %
32.11%
Holding
999
New
156
Increased
303
Reduced
370
Closed
127

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$1.35B
2
INSM icon
Insmed
INSM
+$197M
3
HUBB icon
Hubbell
HUBB
+$191M
4
ARGX icon
argenx
ARGX
+$164M
5
SLNO
Soleno Therapeutics
SLNO
+$161M

Sector Composition

Rank Sector Weight
1 Technology 30.31%
2 Healthcare 13.97%
3 Financials 11.89%
4 Consumer Discretionary 9.55%
5 Communication Services 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOW icon
551
Dow Inc
DOW
$21.9B
$14.8M 0.02%
645,300
+547,900
+563% +$13.7M
LXP icon
552
LXP Industrial Trust
LXP
$3.57B
$14.8M 0.02%
330,000
+70,000
+27% +$3.01M
MGA icon
553
Magna International
MGA
$18.1B
$14.8M 0.02%
+311,576
New +$13.7M
MMSI icon
554
Merit Medical Systems
MMSI
$5.24B
$14.7M 0.02%
176,162
+23,413
+15% +$2.04M
BWA icon
555
BorgWarner
BWA
$13.5B
$14.6M 0.02%
333,000
-778,000
-70% -$31.1M
WST icon
556
West Pharmaceutical
WST
$24.5B
$14.6M 0.02%
55,507
-10,300
-16% -$2.5M
SILA
557
DELISTED
Sila Realty Trust
SILA
$14.5M 0.02%
578,105
+188,105
+48% +$4.68M
WTFC icon
558
Wintrust Financial
WTFC
$10.7B
$14.5M 0.02%
109,200
-11,800
-10% -$1.56M
ICUI icon
559
ICU Medical
ICUI
$4.16B
$14.4M 0.02%
+119,862
New +$15.2M
IFF icon
560
International Flavors & Fragrances
IFF
$21.6B
$14.4M 0.02%
233,300
-1,000
-0.4% -$68.7K
FR icon
561
First Industrial Realty Trust
FR
$8.4B
$14.1M 0.02%
274,756
+162,661
+145% +$8.17M
TSN icon
562
Tyson Foods
TSN
$20.6B
$14.1M 0.02%
260,155
-2,000
-0.8% -$110K
SF
563
Stifel
SF
$12.6B
$14.1M 0.02%
186,000
-120,000
-39% -$8.98M
ALE
564
DELISTED
Allete
ALE
$14M 0.02%
+211,555
New +$13.7M
DEC
565
Diversified Energy Company
DEC
$932M
$14M 0.02%
+1,000,000
New +$15M
MIST icon
566
Milestone Pharmaceuticals
MIST
$147M
$14M 0.02%
+6,976,000
New +$12.3M
DXCM icon
567
DexCom
DXCM
$31.3B
$13.9M 0.02%
207,000
-201,689
-49% -$16M
GEO icon
568
The GEO Group
GEO
$4.03B
$13.8M 0.02%
+675,000
New +$15.4M
MTD icon
569
Mettler-Toledo International
MTD
$28.5B
$13.8M 0.02%
11,257
-2,800
-20% -$3.51M
OTTR icon
570
Otter Tail
OTTR
$3.91B
$13.5M 0.02%
165,000
-20,000
-11% -$1.62M
LEN icon
571
Lennar Class A
LEN
$20.4B
$13.5M 0.02%
+107,217
New +$13.3M
LATAU
572
Galata Acquisition Corp. II Units
LATAU
$13.5M 0.02%
+1,350,000
New +$13.5M
KYMR icon
573
Kymera Therapeutics
KYMR
$8.75B
$13.5M 0.02%
238,000
-66,200
-22% -$2.99M
ON icon
574
ON Semiconductor
ON
$18.6B
$13.4M 0.02%
272,300
+39,600
+17% +$2.08M
RAPP
575
Rapport Therapeutics
RAPP
$2.22B
$13.4M 0.02%
+450,000
New +$8.03M

Similar funds

Adage Capital Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Adage Capital Partners held 999 positions worth $63.1B, up 6.4% from $59.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Adage Capital Partners's Q3 2025 filing shows 156 new, 303 increased, 370 reduced and 127 closed positions. Its largest new stake was Chevron: 3,284,841 shares worth $510M. The largest sale was Hess, an estimated $1.35B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2025 buy was Chevron: 3,284,841 shares worth $510M.
  • Adage Capital Partners added most to Royalty Pharma in Q3 2025, an estimated $216M increase.
  • Adage Capital Partners's biggest Q3 2025 reduction was Insmed, cutting an estimated $197M.
  • Adage Capital Partners fully exited Hess in Q3 2025, selling an estimated $1.35B.
  • Adage Capital Partners's ten largest holdings make up 32% of its $63.1B portfolio in Q3 2025.
  • Adage Capital Partners opened 156 new positions and closed 127 in Q3 2025.
  • Adage Capital Partners's portfolio value rose 6.4% quarter-over-quarter to $63.1B.

Based on Adage Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.